Health Report: Sep. 20, 1993


-- The National Academy of Sciences says the fda should begin the approval process for RU-486, the so-called French abortion pill. The drug has already been tested in Europe. Besides preventing pregnancy, it may be useful in treating fibroid tumors, endometriosis and even cancer.

-- The FDA has approved tacrine, the first drug shown to have an effect, though limited, on Alzheimer's disease.

-- Doctors have devised an in utero operation for treating myelomeningocele, a birth defect in which the spinal cord protrudes from the spine, leading to paralysis and incontinence. The operation, which uses a skin graft...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!